Changes in scale in automated pharmaceutical research

The trend towards increased throughput pervades the drug discovery process. Developments in combinatorial chemistry have made available greater numbers of compounds for high-throughput screening, and advances in genomics have led to increased numbers of potential targets. These advances have been implemented by integration of sophisticated engineering and logistics. The author describes the current automated technologies used within the pharmaceutical industry and explains how continued advances in this area are necessary for maintaining growth of the industry.